Navigation Links
Avanir Pharmaceuticals Announces Results for Phase II PRIME Study
Date:12/10/2013

ALISO VIEJO, Calif., Dec. 10, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

In the PRIME study, AVP-923 treated patients experienced levels of pain reduction commensurate with those observed in similar studies and the improvement in pain scores from baseline reached statistical significance; however, there was no difference between the treatment arms and placebo.  Avanir believes that a higher than expected placebo response negatively impacted the study results.  AVP-923 was generally safe and well tolerated.

Avanir plans to review the detailed data from the PRIME study in conjunction with previously generated data in diabetic peripheral neuropathic pain to determine next steps for the development of AVP-923 in neuropathic pain.

About the PRIME Study
The objectives of the PRIME (Pain Research In Multiple sclErosis) study were to evaluate the safety, tolerability, and efficacy of AVP-923 for the treatment of central neuropathic pain in patients with multiple sclerosis. The trial was a multicenter, randomized, double-blind, placebo-controlled, 4-arm parallel group study that enrolled 209 patients. Eligible patients received one of three dose levels of AVP-923 containing either 45mg DM/10 mg Q, 30mg DM/10mg Q, 20mg DM/10mg Q or placebo, daily for 12 weeks. The primary efficacy endpoint was measured based on the Numeric Pain Rating Scale (PRS) as recorded in patient diaries. Primary analysis of this endpoint correlated pain
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
2. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
3. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
4. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
5. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
7. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
8. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
9. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
10. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
11. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  Array BioPharma Inc. (Nasdaq:   ARRY) ... quarter and full year of fiscal 2014 ... those results on Tuesday, August 12, 2014.  ... Michael Carruthers , Chief Financial Officer will ... 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass Code: ...
(Date:7/28/2014)...  Houston dentist , Dr. Behzad ... with Invisalign. With access to this increasingly popular ... straightened without feeling self-conscious in the process. Invisalign ... types of braces, but patients who choose Invisalign ... better support for their oral health and comfort ...
(Date:7/28/2014)... , 28 luglio 2014 ResMed (NYSE: ... prodotti per la cura dei disturbi respiratori del sonno ... avuto un,ingiunzione permanente in Germania contro il produttore Taiwanese ... la vendita di apparecchiature da indossare in testa, che ... le maschere 220. La sentenza della Corte Regionale Distrettuale ...
Breaking Medicine Technology:Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2
(Date:7/28/2014)... Abington, PA (PRWEB) July 28, 2014 ... solutions provider for the healthcare industry, went live in ... and surpassed the basic standards of excellence that comprise ... specifically for excellence in Healthcare. , “What pleases me ... both the content and usability categories,” said Joshua Snow, ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A St. ... of adult survivors of childhood cancer more than doubled ... problems by failing to follow a heart-healthy lifestyle. The ... Cancer. , Almost 32 percent of the 1,598 adult ... syndrome, an umbrella term for health risk factors like ...
(Date:7/28/2014)... University is proposing a new theory to explain why ... don,t necessarily show declines in the workplace or daily ... adults are to maintain focus on cognitive tasks. , ... difference we see in cognitive performance in different settings," ... NC State and author of a paper describing the ...
(Date:7/28/2014)... Northridge, CA (PRWEB) July 28, 2014 ... a $100 coupon for new patients. Finding a new dentist ... anxiety or dental issues that have gone untreated and worry ... provider. Dr. Ariz specializes in patients with special concerns and ... patients feels comfortable and right at home. This special coupon ...
(Date:7/28/2014)... Freeonlinelifeinsuranceleads.com has released a new blog ... insurance quotes. , Comparing life insurance quotes can help ... costs. Finding affordable coverage is easier online by visiting ... agencies and displays them on a single web page. ... find cheaper coverage, but they can also learn more ...
Breaking Medicine News(10 mins):Health News:Abington Health Website Named Best in Class 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 3Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 4Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2
... suggests higher cost-sharing for outpatient visits may increase overall ... co-pays for doctor visits and other outpatient care reduces ... have the unintended consequence of sharply increasing hospitalizations, a ... up inflating overall health-care spending and put vulnerable elderly ...
... , OMAHA, Neb. , Jan. 27 ... new frozen meals for its Cafe Steamers, All ... When faced with lunch and dinner meal decisions, especially in the ... on track, and are not only healthy but also offer variety ...
... Significant Milestone Toward Close of Transaction , TORONTO , ... NYSE: MDZ ), a leading provider of products ... that the Company has received provisional anti-trust approval from the ... of MDS Analytical Technologies to Danaher Corporation ( DHR). , ...
... Adults with chronic rhinosinusitis a debilitating inflammation of the ... back report significantly improved quality of life following ... study led by Oregon Health & Science University (OHSU). ... Otolaryngology Head and Neck Surgery . ...
... from younger mice, researchers found , WEDNESDAY, Jan. 27 (HealthDay ... stem cells in the blood act like young stem cells, ... aging process. , Taking certain factors from the blood of ... stem cells take on the characteristics of younger stem cells. ...
... ... and sports heroes have made headline news with their affairs, lies, and scandals. While ... tawdry details of the betrayers, the spotlight is rarely on the individuals striving to ... the shadows of their betrayers. , ...
Cached Medicine News:Health News:Raising Co-Pays for Doctor Visits Raises Seniors' Hospital Use 2Health News:Raising Co-Pays for Doctor Visits Raises Seniors' Hospital Use 3Health News:Healthy Choice Shatters the Winter Mealtime Rut With 11 Delicious New Frozen Entrees 2Health News:Healthy Choice Shatters the Winter Mealtime Rut With 11 Delicious New Frozen Entrees 3Health News:Surgery helps chronic sinusitis sufferers get relief 2Health News:Aging of Blood Stem Cells May Be Reversible 2Health News:The True Hero Stands in the Shadow of the Betrayer 2
... available in oxygen, air, heliox and CO 2 . ... to best suit your application. With color coded labels ... Amvex Flowmeter is a user friendly device., ,For ... Take-Off add PT to the end of the part ...
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
0-3.5 LPM Oxygen Flowmeter 1/8" NPT Female inlet...
0-15 LPM Oxygen Flowmeter with Ohmeda male inlet...
Medicine Products: